21MA004N Small molecule: Novel JAK2 Inhibitor Piperadine Aniline Derivatives of Ruxolitinib to treat myelofibrosis
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE
The Innovation Office
InnovationMarketing@Moffitt.org
(813) 745-6828